Sat Khattar - Haw Par Independent Director
| HAWPY Stock | USD 28.64 0.00 0.00% |
Director
Mr. Sat Pal Khattar is NonExecutive Independent Director of Haw Par Corporation Ltd. He was a founding partner and later consultant in Messrs KhattarWong with over 40 years experience in the legal profession. He was appointed to the Board on 1 January 1977 and was last reappointed on 29 April 2016. He is Chairman of the Remuneration and Nominating Committees. He is the Chairman and Director of Khattar Holdings Pte Ltd Group of Companies which is principally engaged in investments. He was also Chairman of the Board of Trustees of the Singapore Business Federation and Member of Presidential Council for Minority Rights. He holds a LLM degree and LLB degree from the University of Singapore. He was presented the SICCIDBS SingaporeIndia Business Award in 2009 and was bestowed the Padma Shri award by the President of India in 2011. since 1977.
| Age | 74 |
| Tenure | 47 years |
| Phone | 65 6337 9102 |
| Web | https://www.hawpar.com |
Haw Par Management Efficiency
Haw Par's management efficiency ratios could be used to measure how well Haw Par manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Stacey Cartwright | GlaxoSmithKline PLC ADR | 51 | |
| Claudia Dyckerhoff | Roche Holding Ltd | 51 | |
| Michel Demare | AstraZeneca PLC ADR | 62 | |
| Laurie Glimcher | GlaxoSmithKline PLC ADR | 69 | |
| Frans Houten | Novartis AG ADR | 61 | |
| Urs Rohner | GSK plc | 59 | |
| Nuria Lapena | Grifols SA ADR | N/A | |
| Atsutoshi Ohta | Santen Pharmaceutical Co | N/A | |
| Hans Wijers | GSK plc | 64 | |
| Shantanu Narayen | Pfizer Inc | 57 | |
| Helen Hobbs | Pfizer Inc | 68 | |
| Kenji Morishima | Santen Pharmaceutical Co | N/A | |
| Paul Bulcke | Roche Holding Ltd | 64 | |
| James Kilts | Pfizer Inc | 71 | |
| DeAnne Julius | Roche Holding Ltd | 66 | |
| Nancy Andrews | Novartis AG ADR | 63 | |
| Ton Buechner | Novartis AG ADR | 55 | |
| Philip Hampton | GSK plc | 64 | |
| Judy Lewent | GlaxoSmithKline PLC ADR | 71 | |
| Diane Souza | Sanofi ADR | 65 | |
| Anita Hauser | Roche Holding Ltd | 49 | |
Management Performance
| Return On Equity | 0.0424 | |||
| Return On Asset | 0.0063 |
Haw Par Leadership Team
Elected by the shareholders, the Haw Par's board of directors comprises two types of representatives: Haw Par inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Haw. The board's role is to monitor Haw Par's management team and ensure that shareholders' interests are well served. Haw Par's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Haw Par's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sat Khattar, Independent Director | ||
| Siew Shiu, Acting Group Internal Audit Manager | ||
| Meng Kwek, Regional General Manager of Underwater World Singapore Pte Ltd / Haw Par Leisure Pte Ltd | ||
| Swee Sim, Non-Executive Independent Director | ||
| Cho Wee, Non-Executive, Non Independent Chairman of the Board | ||
| Chua Keeth, Deputy General Manager - Marketing of Haw Par Healthcare Limited | ||
| Wah Ng, Deputy General Manager-Manufacturing of Healthcare | ||
| Ee Wee, CEO and President Director, Member of Investment Committee, CEO of Haw Par Healthcare Limited and Acting President of Haw Par Healthcare Limited | ||
| Mui Kow, Senior Manager-Quality & Regulatory Affairs of Healthcare | ||
| Brian Loo, Group Mang | ||
| Peter Chew, Deputy General Manager of Underwater World Singapore Pte Ltd | ||
| Kia Chew, Non-Executive Independent Director | ||
| Choon Chew, Non-Executive Independent Director | ||
| Tang Lee, Mang Communications | ||
| Tang Chow, Human Director | ||
| Anthony Chang, Curator of Underwater World Singapore Pte Ltd | ||
| Suan Lee, Non-Executive Independent Director | ||
| Kun Chiew, Group Sec | ||
| Ah Han, Executive Director, Member of Investment Committee, General Manager of Haw Par Healthcare Limited and Director of Haw Par Healthcare Limited | ||
| Hiang Gn, Non-Executive Independent Director | ||
| Seok Lim, CFO and Company Secretary | ||
| Sien Tarn, General Manager - Corporate Development & Property Division | ||
| Sung Whang, General Manager of Underwater World Pattaya Ltd | ||
| Soo Hwang, Non-Executive Independent Director | ||
| Bee Goh, Director & General Manager - Manufacturing of Haw Par Healthcare Limited | ||
| Eechao Wee, Non-Executive Non Independent Director | ||
| Say Chow, Group Finance Controller | ||
| Jasmin Hong, Deputy General Manager - Marketing of Haw Par Healthcare Limited | ||
| Kay Lee, Company Secretary |
Haw Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Haw Par a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0424 | |||
| Return On Asset | 0.0063 | |||
| Profit Margin | 0.79 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | (701.58 M) | |||
| Shares Outstanding | 55.34 M | |||
| Price To Earning | 21.33 X | |||
| Price To Book | 0.73 X | |||
| Price To Sales | 10.01 X | |||
| Revenue | 141.18 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Haw Par in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Haw Par's short interest history, or implied volatility extrapolated from Haw Par options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Haw Par. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Haw Pink Sheet analysis
When running Haw Par's price analysis, check to measure Haw Par's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haw Par is operating at the current time. Most of Haw Par's value examination focuses on studying past and present price action to predict the probability of Haw Par's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haw Par's price. Additionally, you may evaluate how the addition of Haw Par to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance |